Mahmood Mahmood HassanHassan,, MDMD,, PhPh..DD..

Diversified Career inDiversified Career in Neurosurgery Neurosurgery

accross Continents accross Continents

Dhaka Medical Dhaka Medical GraduateGraduate

DMC played a pioneering role DMC played a pioneering role in medical science in medical science development , development , health care delivery &health care delivery &in nation building activitiesin nation building activities

Post Graduation from Post Graduation from KUKU

Residency TrainingResidency Training

• Full time residentialFull time residential• Advance Clinical training with medico legal Advance Clinical training with medico legal protectionprotection• Earned PhD degree with 11 required creditsEarned PhD degree with 11 required credits• Attended all annual neurosurgical meetings Attended all annual neurosurgical meetings activelyactively• Played active role in NUYNA Played active role in NUYNA • Published several papers Published several papers • Flew to Edinburgh, UK to Flew to Edinburgh, UK to attend attend Miller memorial meetingMiller memorial meeting• Accepted by Harvard University Accepted by Harvard University for fellowship for fellowship

Works on NPH & Shunt Works on NPH & Shunt ValveValve

MGH: Top of the worldMGH: Top of the world

http://neurosurgery.mgh.harvard.edu/fellows/hassan

In MGH, BostonIn MGH, Boston

MGH ExperienceMGH Experience

• Attended breakfast Attended breakfast meetings meetings in Ether Domein Ether Dome• Observed surgical Observed surgical proceduresprocedures• Went to Children Hospital &Went to Children Hospital & Brigham Women’s Hospital Brigham Women’s Hospital • Approved with permanent Approved with permanent residency statusresidency status• Attended CNS meeting, 1998Attended CNS meeting, 1998

to receive to receive International International FellowshipFellowship award award

• Published paper on strokePublished paper on stroke

Published paper on Published paper on strokestroke

(TTC)-stained coronalsections

Reduction in infarct volumes independent administration of Mexiletine (60 mg/kg, i.p.) or Magnesium (Mg++, 90 mg/kg, i.a.).

Infarcts are observed (pale region) representativeof the MCA perfusion region

Summary

Mexiletine protects against focal cerebral ischemia, when administered up to 30 min after the onset of permanent MCA occlusion

Did not favor the concurrent use of Mexiletine plus Mg21 for limiting brain injury induced by permanent MCA occlusion

WhereWhereExcellence in the disciplineExcellence in the discipline

Achieved well…..Achieved well…..

High Speed drill WorkshopHigh Speed drill Workshop

Paper Published in Neurosurgery Paper Published in Neurosurgery

Mentor of MentorsMentor of Mentors

Practicing Practicing in Tucsonin Tucson

Returning to help Returning to help people people

Pledged to give my Pledged to give my all…all…